医疗补助计划受益者中的宫颈癌筛查模式
这项回顾性队列研究利用IBM Watson Health多州医疗补助计划市场扫描数据库,分析了2013至2016年间30-64岁平均风险女性接受宫颈癌筛查的模式。共识别265083名患者,其中43.1%接受联合检测,55.2%接受细胞学检查,1.7%接受 primary HPV 检测。结论认为医疗补助计划受益者中宫颈癌筛查常被过度使用,且未接受筛查的女性不太可能进行常规妇科检查。
要点
- 医疗补助计划受益者中宫颈癌筛查常被过度使用。
- 未接受宫颈癌筛查的女性不太可能进行常规妇科检查。
- 索引检测后3年内重复筛查的累积发生率为33.3%。
核心结论
- 在平均风险的医疗补助计划受益者中,宫颈癌筛查常被过度使用。
- 未接受宫颈癌筛查的女性不太可能进行常规妇科检查。
研究设计与样本
- 回顾性队列研究,使用IBM Watson Health多州医疗补助计划市场扫描数据库。
- 研究对象为2013至2016年间接受宫颈癌筛查的30-64岁平均风险女性。
- 共识别265083名患者。
主要发现
- 总体中,43.1%(n=114312)接受索引联合检测,55.2%(n=146309)接受细胞学检查,1.7%(n=4462)接受 primary HPV 检测。
- 早期重复宫颈癌筛查的累积发生率在12个月时为3.9%,24个月时为22.7%,36个月时为33.3%。
- 随访12至24个月期间,20.9%的女性接受重复筛查;索引检测后24-36个月期间,19.4%接受重复筛查。
- 未接受重复宫颈癌筛查的女性中,第2年仅有16627名(10.7%)进行了年度妇科检查,第3年仅有11116名(8.8%)进行了年度妇科检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cervical cancer screening guidelines have evolved over time with the incorporation of human papillomavirus (HPV) testing along with cytology. Current screening guidelines recommend cytological screening every 3 years or HPV testing with or without cytology every 5 years in women age 30-65 years. We examined the use of cervical cancer screening among average-risk Medicaid beneficiaries. DESIGN: Retrospective cohort study. POPULATION: Women age 30-64 years at average risk for cervical cancer who underwent cervical cancer screening with cytology, co-testing or primary HPV testing from 2013 to 2016. METHODS: The IBM Watson Health Multi-State Medicaid MarketScan Database was used. Subsequent screening rates within 3 years of the index test were examined. MAIN OUTCOME MEASURE: The rate of repeat cervical cancer screening was analysed using a cumulative incidence function. RESULTS: A total of 265 083 patients were identified. Overall, 43.1% (n = 114 312) had index co-testing, 55.2% (n = 146 309) had cytology and 1.7% (n = 4462) had primary HPV testing. The cumulative incidence of early, repeat cervical cancer screening was 3.9% at 12 months, 22.7% at 24 months and 33.3% at 36 months. During the period from 12 to 24 months after follow up, 20.9% of women underwent repeat screening while 19.4% underwent repeat screening 24-36 months after the index test. Among women who did not undergo repeat cervical cancer screening, a yearly gynaecological examination was performed in only 16 627 (10.7%) during year 2 and in 11 116 (8.8%) during year 3. CONCLUSION: Among average-risk Medicaid beneficiaries, cervical cancer screening is frequently overused. Women who do not undergo cervical cancer screening are unlikely to undergo routine gynaecological examination. TWEETABLE ABSTRACT: Among average-risk Medicaid beneficiaries, cervical cancer screening is frequently overused.
引用
- Dillon J, Chen L, Melamed A, et al. Patterns of cervical cancer screening among Medicaid beneficiaries. BJOG. 2021. PMID: 34882962. doi:10.1111/1471-0528.17050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。